Basal Cell Carcinomas Treated With Ablative Fractional Laser and Ingenol Mebutate
Status:
Completed
Trial end date:
2018-05-18
Target enrollment:
Participant gender:
Summary
A prospective clinical, uncontrolled, open-label, explorative phase 2a trial on patients with
histologically-confirmed superficial and nodular basal cell carcinoma (BCC). The study
assesses tolerability and tumor clearance after laser-assisted topical delivery of topical
ingenol mebutate.